The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Zeria's Japan sales performance.
Keytruda is currently approved in the US, Europe and Japan in combination with axitinib for the first-line treatment of patients with advanced renal cell carcinoma.
Japan’s healthcare needs. Japan’s healthcare economy has evolved immensely since WWII. ... Historically, Japan has struggled to recruit patients and conduct trials within its domestic population.
The company said its would leverage its presence in Japan and other Asia-Pacific markets to maximise the potential of bemarituzumab in the gastric cancer market.
Using this approach, the analysis found that five countries – Australia, Canada, Japan, the UK and the US – plus the European Union, that is made up of 27 member states, could share
Pakistan, Egypt, Japan (to certain of the brands) and China.
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...